Why the study?
Implantable vascular devices for chronic cardiovascular disease face substantial regulatory hurdles and biological challenges, including inflammation and thrombosis, that can impair functionality and cause adverse events.
Design
Review
Key result
Vascular implantable devices offer benefits for chronic cardiovascular disease management but face significant regulatory and biological challenges, including inflammation and thrombosis.
Authors
Loading...
Urges caution with vascular implants due to thrombosis and inflammation risks; leaves open needs for regulatory and material innovations.
This review outlines the regulatory and biological challenges, such as thrombosis and inflammation, associated with implantable vascular devices for chronic cardiovascular diseases.
Babboni et al. (2025) conducted a review in Chronic cardiovascular diseases (CVDs). Vascular implantable devices was evaluated. Vascular implantable devices offer benefits for chronic cardiovascular disease management but face significant regulatory and biological challenges, including inflammation and thrombosis.